Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
16.71
-0.05 (-0.30%)
At close: Apr 1, 2025, 4:00 PM
16.63
-0.08 (-0.48%)
After-hours: Apr 1, 2025, 4:14 PM EDT

Telix Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
5,5895,0982,2241,5631,606818
Upgrade
Market Cap Growth
129.18%129.18%42.30%-2.70%96.45%196.48%
Upgrade
Enterprise Value
5,5085,0382,1441,4821,572801
Upgrade
Last Close Price
16.7615.40----
Upgrade
PE Ratio
186.73165.02626.21---
Upgrade
PS Ratio
11.5310.526.4914.37290.85203.33
Upgrade
PB Ratio
15.8914.5021.9128.751023.7813.41
Upgrade
P/TBV Ratio
54.1754.1783.14109.40-53.46
Upgrade
P/FCF Ratio
626.10578.16229.72--619.12
Upgrade
P/OCF Ratio
209.87191.44136.63--540.78
Upgrade
EV/Sales Ratio
11.3610.396.2613.62284.54199.24
Upgrade
EV/EBITDA Ratio
101.6292.9555.00---
Upgrade
EV/EBIT Ratio
108.6799.4160.60---
Upgrade
EV/FCF Ratio
617.03571.37221.37--606.68
Upgrade
Debt / Equity Ratio
1.021.020.120.131.180.03
Upgrade
Debt / EBITDA Ratio
6.476.470.30---
Upgrade
Debt / FCF Ratio
40.8140.811.23--1.29
Upgrade
Asset Turnover
0.820.821.520.880.060.04
Upgrade
Inventory Turnover
10.7910.7915.3610.921.253.45
Upgrade
Quick Ratio
2.602.601.181.901.134.62
Upgrade
Current Ratio
2.782.781.412.031.254.69
Upgrade
Return on Equity (ROE)
13.92%13.92%4.55%-253.34%-198.36%-60.21%
Upgrade
Return on Assets (ROA)
5.33%5.33%9.81%-25.37%-37.95%-23.64%
Upgrade
Return on Capital (ROIC)
7.78%7.78%25.26%-97.35%-118.20%-40.13%
Upgrade
Return on Capital Employed (ROCE)
6.90%6.90%21.50%---
Upgrade
Earnings Yield
0.55%0.61%0.16%-4.53%-3.64%-4.23%
Upgrade
FCF Yield
0.16%0.17%0.43%-3.09%-2.75%0.16%
Upgrade
Buyback Yield / Dilution
-6.64%-6.64%-4.21%-10.08%-9.69%-10.21%
Upgrade
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q